X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (94) 94
hygiene (94) 94
medical or veterinary science (94) 94
specific therapeutic activity of chemical compounds ormedicinal preparations (93) 93
preparations for medical, dental, or toilet purposes (92) 92
chemistry (87) 87
heterocyclic compounds (87) 87
metallurgy (87) 87
organic chemistry (87) 87
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (25) 25
animals (25) 25
rats (20) 20
male (15) 15
rats, wistar (13) 13
neurosciences (11) 11
humans (8) 8
brain (7) 7
central-nervous-system (7) 7
pharmacology & pharmacy (7) 7
biochemistry & molecular biology (6) 6
brain - metabolism (6) 6
cells, cultured (6) 6
mice (6) 6
autoradiography (5) 5
dopamine (5) 5
dopamine - metabolism (5) 5
binding (4) 4
blood-brain barrier (4) 4
cell biology (4) 4
index medicus (4) 4
multiple sclerosis (4) 4
neurons (4) 4
animal model (3) 3
biology (3) 3
cell line (3) 3
cells (3) 3
chemistry, medicinal (3) 3
dose-response relationship, drug (3) 3
expression (3) 3
female (3) 3
flesinoxan, enantiomer (3) 3
hyperthermia, stress-induced (3) 3
immunohistochemistry (3) 3
in vitro techniques (3) 3
in-vitro (3) 3
inhibition (3) 3
mouse (3) 3
multiple-sclerosis (3) 3
peptide fragments - pharmacology (3) 3
radioligand assay (3) 3
receptor, serotonin, 5-ht1a - genetics (3) 3
receptors, dopamine d2 - metabolism (3) 3
rodents (3) 3
structure-activity relationship (3) 3
ventral tegmental area (3) 3
way 100635 (3) 3
5-ht (2) 2
5-ht 1a receptor (2) 2
5-ht1a receptor (2) 2
8-oh-dpat-induced hypothermia (2) 2
activation (2) 2
active transport, cell nucleus (2) 2
adenylate cyclase (2) 2
adenylyl cyclases - metabolism (2) 2
aged, 80 and over (2) 2
amino acid sequence (2) 2
amygdala - pathology (2) 2
analgesics - pharmacology (2) 2
animals, newborn (2) 2
anxiety (2) 2
benzocycloheptapyrazole (2) 2
binding, competitive (2) 2
blood-brain barrier - metabolism (2) 2
blood–brain barrier (2) 2
body temperature (2) 2
brain - blood supply (2) 2
brain research (2) 2
catecholamines - metabolism (2) 2
cho cells (2) 2
cricetinae (2) 2
cytokines (2) 2
development (2) 2
disease models, animal (2) 2
dopamine - physiology (2) 2
down-regulation (2) 2
drug design (2) 2
drugs (2) 2
du 125530 (2) 2
electric stimulation (2) 2
endothelium, vascular - cytology (2) 2
fty720 (2) 2
fty720p (2) 2
hydrogen-ion concentration (2) 2
hypothalamus - metabolism (2) 2
inflammation (2) 2
ligands (2) 2
lipoproteins, ldl - metabolism (2) 2
lysophosphatidylcholines - metabolism (2) 2
macrophages - metabolism (2) 2
membrane proteins (2) 2
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (118) 118
French (31) 31
German (20) 20
Spanish (12) 12
Portuguese (4) 4
Chinese (3) 3
Norwegian (3) 3
Czech (2) 2
Danish (2) 2
Polish (2) 2
Slovak (2) 2
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of neuroinflammation, ISSN 1742-2094, 2012, Volume 9, Issue 1, pp. 133 - 133
Journal Article
Psychopharmacology (Berl), ISSN 0033-3158, 2008, Volume 200, Issue 3, pp. 367 - 380
Journal Article
Glia, ISSN 0894-1491, 2010, Volume 58, Issue 12, pp. 1465 - 1476
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2004, Volume 47, Issue 3, pp. 627 - 643
A series of novel 3,4-diarylpyrazolines was synthesized and evaluated in cannabinoid (hCB(1) and hCB(2)) receptor assays. The 3,4-diarylpyrazolines elicited... 
CHEMISTRY, MEDICINAL | INHIBITION | DRUGS | SURFACE | CONFORMATION | ORAL ABSORPTION | BINDING | BRAIN | SOLUBILITY
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2006, Volume 22, Issue 2, pp. 312 - 322
Chemokine receptors represent promising targets to attenuate inflammatory responses and subsequent secondary damage after brain injury. We studied the response... 
Neuroprotection | CINC-1 | MIP-2 | CXCR2 | CXCL1 | Leukocytes | CXCL2 | Brain injury | Microglia | CONTROLLED CORTICAL IMPACT | BONE-MARROW | MICROGLIAL CELLS | NEUROSCIENCES | MACROPHAGE-INFLAMMATORY PROTEIN-2 | NONPEPTIDE ANTAGONIST | brain injury | CONSTITUTIVE EXPRESSION | MULTIPLE-SCLEROSIS | MARROW-DERIVED CELLS | NEUTROPHIL MIGRATION | neuroprotection | KC | leukocytes | CENTRAL-NERVOUS-SYSTEM | microglia | Neuroimmunomodulation - immunology | Chemokines, CXC - immunology | Rats, Wistar | Nerve Degeneration - physiopathology | Brain Injuries - complications | Male | Gliosis - physiopathology | Nerve Degeneration - metabolism | Cell Movement - immunology | Encephalitis - physiopathology | Microglia - immunology | Encephalitis - metabolism | Brain Damage, Chronic - metabolism | Gliosis - immunology | Chemokines - immunology | Disease Models, Animal | Biomarkers - metabolism | Ectodysplasins | Gliosis - metabolism | Rats | Encephalitis - immunology | Membrane Proteins - immunology | Nerve Degeneration - immunology | Receptors, Interleukin-8B - immunology | Cell Survival - immunology | Tumor Necrosis Factors - immunology | Brain Damage, Chronic - physiopathology | Cell Differentiation - immunology | Animals | Up-Regulation - immunology | Down-Regulation - immunology | Receptors, Interleukin-8B - metabolism | Chemokines, CXC - metabolism | Chemokine CXCL2 | Brain Damage, Chronic - immunology | Chemokine CXCL1 | Brain | Brain damage | Laws, regulations and rules | Neurons | Injuries
Journal Article
Journal Article
Chemical & pharmaceutical bulletin, ISSN 0009-2363, 08/2002, Volume 50, Issue 8, pp. 1109 - 1113
The design, synthesis and biological activities of potent pyrazole-based tricyclic CB_1, receptor antagonists (2) are described. The key synthetic step... 
receptor antagonist | Regiochemistry | Molecular modeling | Benzocycloheptapyrazole
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 2008, Volume 45, Issue 3, pp. 256 - 264
Journal Article
Synapse, ISSN 0887-4476, 12/2006, Volume 60, Issue 8, pp. 599 - 608
Present Parkinson's disease treatment strategies are far from ideal for a variety of reasons; it has therefore been suggested that partial dopamine receptor... 
partial agonist | serotonin | Parkinson's disease | 5‐HT1A | receptor binding | neurochemistry | D2 | D3 | Neurochemistry | Partial agonist | Serotonin | 5-HT | Receptor binding | Serotonin 5-HT1 Receptor Agonists | Benzoxazoles - pharmacology | Rats, Wistar | Humans | Receptors, Dopamine D3 - metabolism | Receptor, Serotonin, 5-HT1A - genetics | Serotonin Receptor Agonists - isolation & purification | Male | Lisuride - pharmacology | Parkinson Disease - drug therapy | Piperazines - chemistry | Receptors, Dopamine D2 - metabolism | Recombinant Fusion Proteins - metabolism | Serotonin Receptor Agonists - pharmacology | Benzoxazoles - isolation & purification | Brain - metabolism | Dose-Response Relationship, Drug | Receptors, Dopamine D3 - genetics | Lisuride - analogs & derivatives | Molecular Structure | Parkinson Disease - metabolism | Radioligand Assay | Cyclic AMP - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | CHO Cells | Dopamine Agonists - pharmacology | Cricetinae | Binding, Competitive - physiology | Colforsin - pharmacology | Brain - physiopathology | Receptors, Dopamine D2 - agonists | Serotonin Receptor Agonists - chemistry | Rats | Parkinson Disease - physiopathology | Piperazines - isolation & purification | Piperazines - pharmacology | Receptors, Dopamine D2 - genetics | Binding, Competitive - drug effects | Brain - drug effects | Dopamine Agonists - isolation & purification | Receptors, Dopamine D3 - agonists | Guanosine 5'-O-(3-Thiotriphosphate) - metabolism | Animals | Benzoxazoles - chemistry | Drug Interactions - physiology | Recombinant Fusion Proteins - genetics | Quinpirole - pharmacology | Dopamine Agonists - chemistry
Journal Article
The International Journal of Neuropsychopharmacology, ISSN 1461-1457, 12/2007, Volume 10, Issue 6, pp. 727 - 739
There is evidence for neurodevelopment disturbances in schizophrenia. In rats, a neonatal basolateral amygdala lesion induces behavioural features in adults... 
Development | Schizophrenia | Animal model | Dopamine | Amygdala | Cannabinoid | amygdala | development | PSYCHIATRY | cannabinoid | NAIVE SCHIZOPHRENIC-PATIENTS | RECEPTOR MESSENGER-RNA | schizophrenia | SOCIAL-BEHAVIOR LATER | NEUROSCIENCES | CLINICAL NEUROLOGY | VENTRAL TEGMENTAL AREA | NEURODEVELOPMENTAL PSYCHOPATHOLOGICAL DISORDERS | POSITRON EMISSION TOMOGRAPHY | MEDIAL PREFRONTAL CORTEX | INDUCED DOPAMINE RELEASE | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | ANIMAL-MODEL | animal model | dopamine | Brain Chemistry - drug effects | Ibotenic Acid - toxicity | Rats, Wistar | Receptors, Dopamine D3 - drug effects | Male | Receptors, Dopamine D2 - metabolism | Receptors, Dopamine D1 - metabolism | Cannabinoid Receptor Modulators - physiology | Animals, Newborn - physiology | Receptors, Dopamine D2 - drug effects | Behavior, Animal - drug effects | Dopamine - metabolism | Receptors, Dopamine D1 - drug effects | Rats | Hydroxyindoleacetic Acid - metabolism | Amygdala - pathology | Autoradiography | Receptor, Cannabinoid, CB1 - metabolism | Animals | Excitatory Amino Acid Agonists - toxicity | Norepinephrine - metabolism | Image Processing, Computer-Assisted | Serotonin - metabolism | Receptor, Cannabinoid, CB1 - drug effects | Biogenic Monoamines - physiology | Amygdala - physiology | Brain | Neurology | Animal behavior | Rodents
Journal Article
Journal Article